BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3568004)

  • 1. Follow-up of moderately elevated serum CEA levels in "healthy patients".
    Fischbach W; Kiel HJ
    Cancer Detect Prev; 1987; 10(1-2):109-12. PubMed ID: 3568004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen (CEA)--a useful marker for the detection of recurrent disease in endometrial carcinoma patients.
    Bruns F; Micke O; Halek G; Schäfer U; Willich N
    Anticancer Res; 2003; 23(2A):1103-6. PubMed ID: 12820355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
    Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
    Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five years' follow-up of patients with elevated carcinoembryonic antigen (CEA) and alcoholic liver disease, with special reference to mortality rate and development of malignancy.
    Bell H; Orjasaeter H
    Hepatogastroenterology; 1983 Aug; 30(4):140-2. PubMed ID: 6629305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
    Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
    Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level.
    Bartal AH; Ayalon D; Cordova T; Avidan S; Robinson E
    Isr J Med Sci; 1983 Sep; 19(9):801-5. PubMed ID: 6643017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial.
    Grossmann I; de Bock GH; Meershoek-Klein Kranenbarg WM; van de Velde CJ; Wiggers T
    Eur J Surg Oncol; 2007 Mar; 33(2):183-7. PubMed ID: 17174516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
    Staab HJ; Ahlemann LM; Koch HL; Anderer FA
    Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
    Lunde OC; Havig O
    Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEA levels in active and non-active malignant tumors.
    Horn Y; Walach N; Zeidman JL; Sharf S
    Neoplasma; 1982; 29(4):463-7. PubMed ID: 7133237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen in cervical cancer: a five-year follow-up.
    Braun P; Leyendecker G
    Cancer Detect Prev; 1983; 6(1-2):249-53. PubMed ID: 6883384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer.
    Ahlemann LM; Staab HJ; Anderer FA
    Biomedicine; 1980 Dec; 32(4):194-9. PubMed ID: 7470582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma.
    al-Jarallah MA; Behbehani AE; el-Nass SA; Temim L; Ebraheem AK; Ali MA; Szymendera JJ
    Eur J Surg Oncol; 1993 Feb; 19(1):74-9. PubMed ID: 8436243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Levels of carcinoembryonic antigen in blood serum and in urine in employees who smoke at the "Pasamon" Industrial Works in Bygdoszcz].
    Gajda M; Tyloch F; Tyloch J; Skok Z; Sujkowska R; Spychalska T
    Med Pr; 1994; 45(4):325-32. PubMed ID: 7968501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.
    Gebauer G; Müller-Ruchholtz W
    Cancer Detect Prev; 2001; 25(4):344-51. PubMed ID: 11531011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Takahashi K; Sasaki Y; Ohkura H
    Gan To Kagaku Ryoho; 1984 May; 11(5):1056-63. PubMed ID: 6202246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
    Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
    Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
    Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M
    Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.